2026-05-20T04:33:50Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/235642025-12-18T13:00:44Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19608col_20.500.12105_19609col_20.500.12105_16971

00925njm 22002777a 4500 dc Palladino, Claudia author Ramis, Rebeca author Ezeonwumelu, Ifeanyi Jude author Biondi, Antonio author Carreras, Giulia author Fischer, Florian author Gallus, Silvano author Golinelli, Davide author Gorini, Giuseppe author Hassan, Shoaib author Kabir, Zubair author Koyanagi, Ai author Lazarus, Jeffrey V author Mentis, Alexios-Fotios A author Meretoja, Tuomo J author Mokdad, Ali H author Monasta, Lorenzo author Mulita, Francesk author Postma, Maarten J author Tabarés-Seisdedos, Rafael author Thiyagarajan, Arulmani author Taveira, Nuno author Briz, Veronica author GBD 2019 Southern Europe Hepatitis B & C Collaborators author 2024-06-20 Background: The economic crisis that began in 2008 has severely affected Southern (Greece, Italy, Portugal, Spain) Western European (SWE) countries of Western Europe (WE) and may have affected ongoing efforts to eliminate viral hepatitis. This study was conducted to investigate the impact of the economic crisis on the burden of HBV and HCV disease. Methods: Global Burden of Diseases 2019 data were used to analyse the rates of epidemiological metrics of HBV and HCV acute and chronic infections in SWE and WE. Time series modelling was performed to quantify the impact of healthcare expenditure on the time trend of HBV and HCV disease burden in 2000-2019. Results: Declining trends in incidence and prevalence rates of acute HBV (aHBV) and chronic HBV were observed in SWE and WE, with the pace of decline being slower in the post-austerity period (2010-2019) and mortality due to HBV stabilised in SWE. Acute HCV (aHCV) metrics and chronic HCV incidence and mortality showed a stable trend in SWE and WE, whereas the prevalence of chronic HCV showed an oscillating trend, decreasing in WE in 2010-2019 (p < 0.001). Liver cancer due to both hepatitis infections showed a stagnant burden over time. An inverse association was observed between health expenditure and metrics of both acute and chronic HBV and HCV. Conclusions: Epidemiological metrics for HBV and HCV showed a slower pace of decline in the post-austerity period with better improvement for HBV, a stabilisation of mortality and a stagnant burden for liver cancer due to both hepatitis infections. The economic crisis of 2008 had a negative impact on the burden of hepatitis B and C. Elimination of HBV and HCV by 2030 will be a major challenge in the SWE countries. BMC Public Health. 2024 Jun 20;24(1):1642. 10.1186/s12889-024-18912-0 1471-2458 1471-2458 BMC Public Health 38902642 https://hdl.handle.net/20.500.12105/23564 Chronic liver diseases Cirrhosis Drugs Economic crisis Epidemiology Global burden of disease Hepatitis B Hepatitis C Liver cancer Southern European countries Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries